Purchases and Sales Made in Q2 2022 in Intra Cellular Therapies, Inc. (ITCI)
This table provides information about the institutional ownership of Intra Cellular Therapies, Inc. (ITCI) during Q2 2022. The information is specifically focused on institutions that hold shares of Intra-Cellular Therapies, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 15, 2022
Q2 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-193K- 32.27% |
$8.31M - $12.7M
|
406K
$34M
|
|
Jul 29, 2022
Q2 2022
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-336K- 75.5% |
$14.4M - $22M
|
109K
$9.11M
|
|
Aug 09, 2022
Q2 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-372K- 25.04% |
$16M - $24.4M
|
1.11M
$93.2M
|
|
Aug 11, 2022
Q2 2022
|
Brandywine Global Investment Management, LLC
Philadelphia, PA |
SELL
|
- |
-537K- 94.46% |
$23.1M - $35.3M
|
31.5K
$2.64M
|
|
Aug 12, 2022
Q2 2022
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-2.09M- 27.91% |
$89.7M - $137M
|
5.39M
$451M
|
|
Aug 15, 2022
Q2 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-2.52MClosed |
$108M - $165M
|
0
$0
|